Preferred growth direction by PbS nanoplatelets preserves perovskite infrared light harvesting for stable, reproducible, and efficient solar cells

Formamidinium-based perovskite solar cells (PSCs) present the maximum theoretical efficiency of the lead perovskite family. However, formamidinium perovskite exhibits significant degradation in air. The surface chemistry of PbS has been used to improve the formamidinium black phase stability. Here, the use of PbS nanoplatelets with (100) preferential crystal orientation is reported, to potentiate the repercussion on the crystal growth of perovskite grains and to improve the stability of the material and consequently of the solar cells. As a result, a vertical growth of perovskite grains, a stable current density of 23 mA cm(-2), and a stable incident photon to current efficiency in the infrared region of the spectrum for 4 months is obtained, one of the best stability achievements for planar PSCs. Moreover, a better reproducibility than the control device, by optimizing the PbS concentration in the perovskite matrix, is achieved. These outcomes validate the synergistic use of PbS nanoplatelets to improve formamidinium long-term stability and performance reproducibility, and pave the way for using metastable perovskite active phases preserving their light harvesting capability

Recomendações Para O Tratamento Da Crise Migranosa - Um Consenso Brasileiro

In this article, a group of experts in headache management of the Brazilian Headache Society developed through a consensus strategic measurements to treat a migraine attack in both the child and the adult. Particular emphasis was laid on the treatment of migraine in women, including at pregnancy, lactation and perimenstrual period. © 2016, Associacao Arquivos de Neuro-Psiquiatria. All rights reserved.74326227

Quantification of the effects of recombination and injection in the performance of dye-sensitized solar cells based on N-substituted carbazole dyes

Two new sensitizers for dye sensitized solar cells have been designed consisting of thiophene units asymmetrically functionalized by N-aryl carbazole. The di(tert-butyl) carbazole moieties acts as an electron donor group, the thiophene chain as a bridge group, and the cyanoacrylic acid as an anchoring and electron acceptor group. An increase of the conjugation length produces two main effects: first, it leads to a red-shift of the optical absorption of the dyes, resulting in an improved overlap of the absorption with the solar spectrum. Second, the oxidation potential decreases. The photovoltaic performance of this set of dyes as sensitizers in mesoporous TiO2 solar cells was investigated using electrolytes containing the iodide/triiodide redox couple. The dye with the best absorption characteristics showed the highest photocurrent but lower open circuit voltage due to more losses by recombination. A trend between structure (molecule dyes size) and recombination is demostrated using an analysis procedure based on ß-recombination model that combines impedance spectroscopy and density current-voltage data. © 2010 American Chemical Society

Porphyrin Dyes with High Injection and Low Recombination for Highly Efficient Mesoscopic Dye-Sensitized Solar Cells

The photovoltaic performance and charge recombination characteristics of porphyrin-based dye-sensitized solar cell (DSC) devices have been investigated using the impedance spectroscopy (IS) technique. The IS results provide key information related to the device performance for a highly efficient porphyrin dye (YD2), a reference porphyrin dye (YD0), and a commercial ruthenium dye (N719). The DSC devices constructed using YD2 and N719 dyes reach similar internal power conversion efficiencies (7.41% vs 7.54%) due to the higher injection of the YD2 dye that is compromised by a lower photovoltage. In addition, both YD2 and N719 dyes exhibit the same charge-transfer resistance, indicating that the recombination rates of both dyes are very similar. The diarylamino group plays a key role to repel the triiodide ions from the titania surface so that the charge recombination of YD2 is less significant compared with that of YD0

Factors associated with adverse COVID-19 outcomes in patients with psoriasis : insights from a global registry–based study

Background: The multimorbid burden and use of systemic immunosuppressants in people with psoriasis may confer greater risk of adverse outcomes of coronavirus disease 2019 (COVID-19), but the data are limited. Objective: Our aim was to characterize the course of COVID-19 in patients with psoriasis and identify factors associated with hospitalization. Methods: Clinicians reported patients with psoriasis with confirmed/suspected COVID-19 via an international registry, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection. Multiple logistic regression was used to assess the association between clinical and/or demographic characteristics and hospitalization. A separate patient-facing registry characterized risk-mitigating behaviors. Results: Of 374 clinician-reported patients from 25 countries, 71% were receiving a biologic, 18% were receiving a nonbiologic, and 10% were not receiving any systemic treatment for psoriasis. In all, 348 patients (93%) were fully recovered from COVID-19, 77 (21%) were hospitalized, and 9 (2%) died. Increased hospitalization risk was associated with older age (multivariable-adjusted odds ratio [OR] = 1.59 per 10 years; 95% CI = 1.19-2.13), male sex (OR = 2.51; 95% CI = 1.23-5.12), nonwhite ethnicity (OR = 3.15; 95% CI = 1.24-8.03), and comorbid chronic lung disease (OR = 3.87; 95% CI = 1.52-9.83). Hospitalization was more frequent in patients using nonbiologic systemic therapy than in those using biologics (OR = 2.84; 95% CI = 1.31-6.18). No significant differences were found between classes of biologics. Independent patient-reported data (n = 1626 across 48 countries) suggested lower levels of social isolation in individuals receiving nonbiologic systemic therapy than in those receiving biologics (OR = 0.68; 95% CI = 0.50-0.94). Conclusion: In this international case series of patients with moderate-to-severe psoriasis, biologic use was associated with lower risk of COVID-19-related hospitalization than with use of nonbiologic systemic therapies; however, further investigation is warranted on account of potential selection bias and unmeasured confounding. Established risk factors (being older, being male, being of nonwhite ethnicity, and having comorbidities) were associated with higher hospitalization rates